Crossmark

Expert Statement on the Single-Agent Use of Inhaled Bronchodilator in the Treatment of Stable Mild-Moderate Chronic Obstructive Pulmonary Disease

Crossref DOI link: https://doi.org/10.1016/j.arbr.2017.08.013

Published Print: 2017-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Riesco Miranda, Juan Antonio

Alcázar, Bernardino

Alfageme, Inmaculada

Casanova, Ciro

Celli, Bartolomé

de-Torres, Juan P.

Jiménez Ruiz, Carlos A.
License Information

Text and Data Mining valid from 2017-10-01
More Information

This article is maintained by: Elsevier

Article Title: Expert Statement on the Single-Agent Use of Inhaled Bronchodilator in the Treatment of Stable Mild-Moderate Chronic Obstructive Pulmonary Disease

Journal Title: Archivos de Bronconeumología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.arbr.2017.08.013

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.arbres.2017.03.022

Content Type: article

Copyright: © 2017 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.